Founded in 2014, Sofregen develops innovative solutions using silk, derived from technology developed at Tufts University and the University of Pittsburgh. Their biomedical silk protein enables plastic surgeons to enhance their surgical artistry and achieve more durable results. Sofregen's products facilitate soft tissue regeneration, offering a fresh start and restoring confidence for medical and aesthetic patients worldwide. Their Silk Voice® injectable implant & catheter, cleared by the U.S. FDA in 2019, is specifically designed for vocal fold medialization and vocal fold insufficiency, providing a transformative solution for patients in need.